| Human polyomaviruses DNA detection in peripheral blood leukocytes from immunocompetent and immunocompromised individuals A Azzi, R De Santis, S Ciappi, F Leoncini, G Sterrantino, N Marino, ... Journal of neurovirology 2 (6), 411-416, 1996 | 104 | 1996 |
| Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011 A Antinori, S Marcotullio, A Ammassari, M Andreoni, G Angarano, ... New Microbiologica 35 (2), 113-159, 2012 | 82 | 2012 |
| Self-reported adherence supports patient preference for the single tablet regimen (STR) in the current cART era G Sterrantino, L Santoro, D Bartolozzi, M Trotta, M Zaccarelli Patient preference and adherence, 427-433, 2012 | 69 | 2012 |
| Morphologic alterations in HIV-infected people with lipodystrophy are associated with good adherence to HAART G Guaraldi, R Murri, G Orlando, E Orlandi, G Sterrantino, M Borderi, ... HIV Clinical Trials 4 (2), 99-106, 2003 | 62 | 2003 |
| Archetypal and rearranged sequences of human polyomavirus JC transcription control region in peripheral blood leukocytes and in cerebrospinal fluid. S Ciappi, A Azzi, R De Santis, F Leoncini, G Sterrantino, F Mazzotta, ... Journal of general virology 80 (4), 1017-1023, 1999 | 60 | 1999 |
| Long-term data on the efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multi-centre cohort of HIV-1-infected, virologically suppressed patients G Baldin, A Ciccullo, S Rusconi, A Capetti, G Sterrantino, M Colafigli, ... International journal of antimicrobial agents 54 (6), 728-734, 2019 | 59 | 2019 |
| A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks’ observational data AF Capetti, MV Cossu, G Orofino, G Sterrantino, G Cenderello, ... BMC Infectious Diseases 17, 1-7, 2017 | 59 | 2017 |
| Aortic connective tissue in ageing—a biochemical study L Andreotti, A Bussotti, D Cammelli, F di Giovine, S Sampognaro, ... Angiology 36 (12), 872-879, 1985 | 58 | 1985 |
| Switch to dolutegravir plus rilpivirine dual therapy in cART-experienced subjects: an observational cohort AF Capetti, G Sterrantino, MV Cossu, GC Orofino, G Barbarini, ... PLoS One 11 (10), e0164753, 2016 | 56 | 2016 |
| Efficacy and tolerability of dolutegravir and two nucleos (t) ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients A Borghetti, G Baldin, A Capetti, G Sterrantino, S Rusconi, A Latini, ... Aids 31 (3), 457-459, 2017 | 55 | 2017 |
| Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group V Svicher, R D'Arrigo, C Alteri, M Andreoni, G Angarano, A Antinori, ... New Microbiologica 33 (3), 195-206, 2010 | 55 | 2010 |
| Efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicentre cohort of patients with suppressed HIV‐1 replication A Borghetti, G Baldin, F Lombardi, A Ciccullo, A Capetti, S Rusconi, ... HIV medicine 19 (7), 452-454, 2018 | 53 | 2018 |
| Human papilloma virus type 16 E6 gene expression in oral exophytic epithelial lesions as detected by in situ rtPCR G Al-Bakkal, G Ficarra, K McNeill, LR Eversole, G Sterrantino, C Birek Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and …, 1999 | 52 | 1999 |
| Chronic cryptosporidiosis in patients with AIDS: stable remission and possible eradication after long-term, low dose azithromycin. D Dionisio, A Orsi, G Sterrantino, M Meli, S Di Lollo, LI Manneschi, ... Journal of clinical pathology 51 (2), 138-142, 1998 | 45 | 1998 |
| Dolutegravir plus rilpivirine as a switch option in cART-experienced patients: 96-week data AF Capetti, MV Cossu, G Sterrantino, G Barbarini, S Di Giambenedetto, ... Annals of Pharmacotherapy 52 (8), 740-746, 2018 | 44 | 2018 |
| A comparison between two dolutegravir-based two-drug regimens as switch strategies in a multicentre cohort of HIV-1-infected patients A Ciccullo, G Baldin, A Capetti, S Rusconi, G Sterrantino, G d'Ettorre, ... Antiviral therapy 24 (1), 63-67, 2019 | 41 | 2019 |
| Burden of disease in PWH harboring a multidrug-resistant virus: data from the PRESTIGIO registry L Galli, MR Parisi, A Poli, M Menozzi, M Fiscon, E Garlassi, D Francisci, ... Open Forum Infectious Diseases 7 (11), ofaa456, 2020 | 40 | 2020 |
| Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus A Castagna, M Ferrara, L Galli, L Comi, G Sterrantino, G Cenderello, ... Journal of Antimicrobial Chemotherapy 73 (1), 177-182, 2018 | 39 | 2018 |
| Rare occurrence of doravirine resistance-associated mutations in HIV-1-infected treatment-naive patients C Soulie, MM Santoro, C Charpentier, A Storto, D Paraskevis, D Di Carlo, ... Journal of Antimicrobial Chemotherapy 74 (3), 614-617, 2019 | 35 | 2019 |
| Efficacy and safety of dolutegravir-based regimens in advanced HIV-infected naïve patients: results from a multicenter cohort study B Rossetti, G Baldin, G Sterrantino, S Rusconi, A De Vito, A Giacometti, ... Antiviral research 169, 104552, 2019 | 34 | 2019 |
Cristina MussiniProfessor of Infectious Diseases, Univ. of Modena and Reggio EmiliaVahvistettu sähköpostiosoite verkkotunnuksessa unimore.it